QQQ   305.97 (+0.35%)
AAPL   157.40 (+1.55%)
MSFT   272.23 (-2.58%)
META   197.81 (+1.12%)
GOOGL   101.22 (-0.39%)
AMZN   97.71 (-1.25%)
TSLA   183.25 (+1.73%)
NVDA   259.00 (+0.68%)
NIO   8.75 (+5.93%)
BABA   81.00 (-0.82%)
AMD   96.81 (-1.05%)
T   18.49 (+1.99%)
F   11.18 (-1.06%)
MU   57.64 (+1.73%)
CGC   1.86 (-7.00%)
GE   89.92 (-0.41%)
DIS   94.22 (+1.09%)
AMC   4.27 (+2.15%)
PFE   40.81 (+1.77%)
PYPL   73.21 (+0.30%)
NFLX   305.13 (+0.54%)
QQQ   305.97 (+0.35%)
AAPL   157.40 (+1.55%)
MSFT   272.23 (-2.58%)
META   197.81 (+1.12%)
GOOGL   101.22 (-0.39%)
AMZN   97.71 (-1.25%)
TSLA   183.25 (+1.73%)
NVDA   259.00 (+0.68%)
NIO   8.75 (+5.93%)
BABA   81.00 (-0.82%)
AMD   96.81 (-1.05%)
T   18.49 (+1.99%)
F   11.18 (-1.06%)
MU   57.64 (+1.73%)
CGC   1.86 (-7.00%)
GE   89.92 (-0.41%)
DIS   94.22 (+1.09%)
AMC   4.27 (+2.15%)
PFE   40.81 (+1.77%)
PYPL   73.21 (+0.30%)
NFLX   305.13 (+0.54%)
QQQ   305.97 (+0.35%)
AAPL   157.40 (+1.55%)
MSFT   272.23 (-2.58%)
META   197.81 (+1.12%)
GOOGL   101.22 (-0.39%)
AMZN   97.71 (-1.25%)
TSLA   183.25 (+1.73%)
NVDA   259.00 (+0.68%)
NIO   8.75 (+5.93%)
BABA   81.00 (-0.82%)
AMD   96.81 (-1.05%)
T   18.49 (+1.99%)
F   11.18 (-1.06%)
MU   57.64 (+1.73%)
CGC   1.86 (-7.00%)
GE   89.92 (-0.41%)
DIS   94.22 (+1.09%)
AMC   4.27 (+2.15%)
PFE   40.81 (+1.77%)
PYPL   73.21 (+0.30%)
NFLX   305.13 (+0.54%)
QQQ   305.97 (+0.35%)
AAPL   157.40 (+1.55%)
MSFT   272.23 (-2.58%)
META   197.81 (+1.12%)
GOOGL   101.22 (-0.39%)
AMZN   97.71 (-1.25%)
TSLA   183.25 (+1.73%)
NVDA   259.00 (+0.68%)
NIO   8.75 (+5.93%)
BABA   81.00 (-0.82%)
AMD   96.81 (-1.05%)
T   18.49 (+1.99%)
F   11.18 (-1.06%)
MU   57.64 (+1.73%)
CGC   1.86 (-7.00%)
GE   89.92 (-0.41%)
DIS   94.22 (+1.09%)
AMC   4.27 (+2.15%)
PFE   40.81 (+1.77%)
PYPL   73.21 (+0.30%)
NFLX   305.13 (+0.54%)

Canopy Growth - CGC Competitors

$1.86
-0.14 (-7.00%)
(As of 03/20/2023 12:00 AM ET)
Add
Compare
Today's Range
$1.85
$2.00
50-Day Range
$1.86
$3.14
52-Week Range
$1.85
$8.79
Volume
7.14 million shs
Average Volume
7.75 million shs
Market Capitalization
$924.49 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$4.53

CGC vs. USNA, CRON, BTMD, GERN, WRBY, TARO, EQRX, GMTX, INBX, and OMI

Should you be buying Canopy Growth stock or one of its competitors? The main competitors of Canopy Growth include USANA Health Sciences (USNA), Cronos Group (CRON), biote (BTMD), Geron (GERN), Warby Parker (WRBY), Taro Pharmaceutical Industries (TARO), EQRx (EQRX), Gemini Therapeutics (GMTX), Inhibrx (INBX), and Owens & Minor (OMI). These companies are all part of the "medical" sector.

Canopy Growth vs.

Canopy Growth (NASDAQ:CGC) and USANA Health Sciences (NYSE:USNA) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their media sentiment, institutional ownership, profitability, analyst recommendations, dividends, community ranking, valuation, earnings and risk.

USANA Health Sciences has a net margin of 6.94% compared to Canopy Growth's net margin of -721.40%. USANA Health Sciences' return on equity of 16.92% beat Canopy Growth's return on equity.

Company Net Margins Return on Equity Return on Assets
Canopy Growth -721.40% -46.02% -24.62%
USANA Health Sciences 6.94% 16.92% 12.15%

Canopy Growth presently has a consensus price target of $4.53, indicating a potential upside of 143.30%. USANA Health Sciences has a consensus price target of $52.75, indicating a potential downside of 14.51%. Given Canopy Growth's stronger consensus rating and higher probable upside, research analysts plainly believe Canopy Growth is more favorable than USANA Health Sciences.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Canopy Growth
6 Sell rating(s)
5 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
1.79
USANA Health Sciences
1 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.50

In the previous week, Canopy Growth's average media sentiment score of 1.73 beat USANA Health Sciences' score of 0.00 indicating that Canopy Growth is being referred to more favorably in the media.

Company Overall Sentiment
Canopy Growth Very Positive
USANA Health Sciences Neutral

Canopy Growth has a beta of 2.08, meaning that its stock price is 108% more volatile than the S&P 500. Comparatively, USANA Health Sciences has a beta of 0.74, meaning that its stock price is 26% less volatile than the S&P 500.

USANA Health Sciences received 359 more outperform votes than Canopy Growth when rated by MarketBeat users. Likewise, 60.16% of users gave USANA Health Sciences an outperform vote while only 21.28% of users gave Canopy Growth an outperform vote.

CompanyUnderperformOutperform
Canopy GrowthOutperform Votes
20
21.28%
Underperform Votes
74
78.72%
USANA Health SciencesOutperform Votes
379
60.16%
Underperform Votes
251
39.84%

15.8% of Canopy Growth shares are owned by institutional investors. Comparatively, 52.6% of USANA Health Sciences shares are owned by institutional investors. 0.2% of Canopy Growth shares are owned by insiders. Comparatively, 0.4% of USANA Health Sciences shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

USANA Health Sciences has higher revenue and earnings than Canopy Growth. Canopy Growth is trading at a lower price-to-earnings ratio than USANA Health Sciences, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Canopy Growth$415.09 million2.23-$241.08 million-$6.01-0.31
USANA Health Sciences$998.60 million1.19$69.35 million$3.5917.19

Summary

USANA Health Sciences beats Canopy Growth on 11 of the 17 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding CGC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

CGC vs. The Competition

MetricCanopy GrowthMedicinals & botanicals IndustryMedical SectorNASDAQ Exchange
Market Cap$924.49M$1.14B$4.22B$5.78B
Dividend YieldN/A4.55%6.03%4.46%
P/E Ratio-0.313.77108.6812.73
Price / Sales2.2328.353,529.9860.22
Price / Cash3.1119.0526.5897.15
Price / Book0.261.664.404.92
Net Income-$241.08M-$102.96M$114.67M$191.77M
7 Day Performance-8.37%-1.12%-1.41%-0.52%
1 Month Performance-25.90%-1.36%-7.95%-8.13%
1 Year Performance-73.88%-49.63%-15.99%-18.29%

Canopy Growth Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
USNA
USANA Health Sciences
1.9175 of 5 stars
$60.22
-1.4%
$52.75
-12.4%
-23.5%$1.16B$998.60M16.771,900
CRON
Cronos Group
2.1783 of 5 stars
$1.94
-2.5%
$3.56
+83.6%
-46.0%$738.33M$91.90M-4.31626
BTMD
biote
2.1619 of 5 stars
$5.15
+6.4%
$10.25
+99.0%
N/A$353.08MN/A0.00N/APositive News
GERN
Geron
2.0186 of 5 stars
$2.62
-4.4%
$5.50
+109.9%
+107.4%$998.82M$1.39M-7.2869Earnings Report
Analyst Report
Gap Down
WRBY
Warby Parker
2.2105 of 5 stars
$10.34
-1.2%
$17.50
+69.2%
-68.8%$995.44M$598.11M-10.663,032
TARO
Taro Pharmaceutical Industries
2.1711 of 5 stars
$27.03
-6.2%
$35.00
+29.5%
-42.9%$1.02B$561.35M22.161,455High Trading Volume
EQRX
EQRx
1.8875 of 5 stars
$2.09
-1.4%
$4.57
+118.5%
-52.8%$1.02BN/A-5.81240
GMTX
Gemini Therapeutics
0 of 5 stars
$22.70
+0.9%
N/A+1,360.4%$983.55MN/A-22.7031News Coverage
INBX
Inhibrx
2.3068 of 5 stars
$22.56
-4.3%
$45.25
+100.6%
-17.3%$982.98M$2.18M-6.23106Gap Down
OMI
Owens & Minor
2.1731 of 5 stars
$12.87
-1.5%
$17.20
+33.6%
-73.0%$981.72M$9.96B45.9713,400Analyst Upgrade
This page (NASDAQ:CGC) was last updated on 3/20/2023 by MarketBeat.com Staff